Gabelli Funds’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
Gabelli Funds's TVTX Position: Q3 2026 in Review
Gabelli Funds reduced its Travere Therapeutics (TVTX) stake by 36% in Q3 2026, selling an estimated $183K and leaving 5,300 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #1123.
Gabelli Funds first reported a position in TVTX in Q2 2026 and has held it in 2 quarters since. The position peaked at $472K in Q2 2026. 345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.
- Gabelli Funds held 5,300 shares of Travere Therapeutics worth $312K as of Q3 2026.
- Gabelli Funds sold 3,000 Travere Therapeutics shares in Q3 2026, an estimated $183K.
- Travere Therapeutics made up ﹤0.01% of Gabelli Funds's portfolio in Q3 2026, its #1123 holding.
- Gabelli Funds first reported a position in Travere Therapeutics in Q2 2026 and has held it in 2 quarters since.
- Gabelli Funds's Travere Therapeutics position peaked at $472K in Q2 2026.
- 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.
Based on Gabelli Funds's 13F filing for Q3 2026, filed 12 Nov 2026.